Enhanced analytical sensitivity of a quantitative PCR for CMV using a modified nucleic-acid extraction procedure

Journal of Clinical Laboratory Analysis

Volumn 14, Issue 1, 2000, Pages 32-37

  Ferreira Gonzalez, Andrea ^a   Yanovich, Saul ^a   Langley, Michael R ^a   Weymouth, Lisa A ^a   Wilkinson, David S ^a   Garrett, Carleton T ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

CMV; CMV viral load; Plasma; Quantitative PCR

Indexed keywords

ARTICLE; BLOOD SAMPLING; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EXTRACTION; HUMAN; IMMUNE DEFICIENCY; POLYMERASE CHAIN REACTION; QUANTITATIVE ASSAY; SERODIAGNOSIS; VIRUS LOAD;

CENTRIFUGATION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; HUMANS; POLYMERASE CHAIN REACTION; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; VIRAL LOAD;

CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; DNA VIRUSES;

EID: 0033963053     PISSN: 08878013     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2825(2000)14:1<32::AID-JCLA7>3.0.CO;2-W     Document Type: Article

References (34)

1. Rubin RH. Infection in the organ transplant recipients. In: Rubin RH, Young LS, editors. Clinical approach to infection in the compromised host, 3rd ed. New York: Plenum Medical Book Company; 1994.
2. Ho M. Epidemiology of cytomegalovirus infections. Rev Infect Dis 1990;12(Suppl 7):701-710.
3. Zaia JA. Cytomegalovirus infection. In: Forman SJ, Blume KG, Thomas ED. editors. Bone marrow transplantation. Boston: Blackwell Scientific Publications; 1994.
4. Zaia JA. Prophylaxis and treatment of CMV infections in transplantation. In: Mills J, Volberding P, Carey L, editors. Fourth triennial symposium on new directions in antiviral chemotherapy. New York: Plenum Medical Book Company; 1995.
5. Rubin RH. Impact of cytomegalovirus infection on organ transplants recipients. Rev Infect Dis 1990;12(Suppl 7):754-766.
6. Stratta RJ, Shaefer MS, Markin RS, et al. Clinical patterns of cytomegalovirus disease after liver transplantation. Arch Surg 1989;124:1443-1449.
7. Singh N, Mieles L, Yu VL, et al. Decreased incidence of viral infections in liver transplant recipients. Possible effects of FK 506? Dig Dis Sci 1994;39:15-18.
8. Farrugía E, Schwab TR. Management and prevention of cytomegalovirus infection after renal transplantation. Mayo Clin Proc 1992;67:879-890.
9. Wiesner RH, Marin E, Porayko MK, et al. Advances in the diagnosis, treatment, and prevention of cytomegalovirus infections after liver transplantation. Gastroenterol Clin North Am 1993;72:351-366.
10. Gleaves CA, Smith, TF, Shuster E, et al. Comparison of standard tube and shell vial culture techniques for the detection of cytomegalovirus in clinical specimens. J Clin Microbiol 1985;21:217-221.
11. Brumback B, Bolejack S, Morris MV, et al. Comparison of culture and the antigenemia assay for detection of cytomegalovirus in blood specimens submitted to a reference laboratory. J Clin Microbiol 1997; 35:1819-1821.
12. Bitsch A, Kirchner H, Dennin R, et al. The long persistence of CMV DNA in the blood of renal transplants patients after recovery from CMV infection. Transplantation 1993;56:108-113.
13. Halwachs G, Zach R, Holzer H, et al. A rapid immunocytochemical assay for CMV detection in peripheral blood of organ transplanted patients in clinical practice. Transplantation 1993;56:338-342.
14. Bein G, Bitsch J, Hoyer J, et al. The detection of human cytomegalovirus immediate early antigen in peripheral blood leukocytes. J Immunology Methods 1991;137:175-180.
15. Boeckh B, Wooghd P, Stevers-Ayers T, et al. Factors influencing detection of quantitative cytomegalovirus antigenemia. J Clin Microbiol 1994;32:832-834.
16. Kidd M, Fox J, Pillay D, et al. Provision of prognostic information in immunocompromised patients by routine application of polymerase chain reaction for cytomegalovirus. Transplantation 1993;56:867-871.
17. Brytting M, Jazi M, Bostrom L, et al. Cytomegalovirus DNA in peripheral bloods leukocytes and plasma from bone marrow transplant recipients. Transplantation 1995;60:961-965.
18. Abecassis M, Koffron A, Kaplan B, et al. The role of PCR in the diagnosis and management of CMV infection in organ recipients. Transplantation 1997;63:275-279.
19. Gozlan J, Salord JM, Choua D, et al. Human cytomegalovirus (HCMV) late mRNA detection in peripheral blood of AIDS patients. Diagnostic value for HCMV disease compared with those of viral culture and HCMV DNA detection. J Clin Microbiol 1993;33:1943-1945.
20. Schofer P, Tenschert W, Gutensahn K, et al. Minimal effect of delayed sample processing on result of quantitative PCR for cytomegalovirus DNA in leukocytes compared to results of antigenemia assay. J Clin Microbiol 1997;35:741-744.
21. Gallez-Hawkins M, Tegtmeier B, Veer A, et al. Evaluation of quantitative plasma PCR plate assay for detecting cytomegalovirus infection in marrow transplant recipients. J Clin Microbiol 1997;35:788-790.
22. Multimer D, Matyi-Toth A, Shaw J, et al. Patterns of viremia in liver transplant recipients with symptomatic cytomegalovirus infection.Transplantation 1997;63(1):68-73.
23. Schafer P, Braun RW, Mohring K, et al. Quantitative determination of human cytomegalovirus target sequences in peripheral blood leukocytes by nested PCR and temperature gradient gel electrophoresis. J Gen Virol 1993;74:2699-2707.
24. Zipeto D, Revello E, Silini M, et al. Quantitation of human cytomegalovirus DNA in peripheral blood polymorphonuclear leukocytes of immunocompromised patients by polymerase chain reaction. J Virol Methods 1993;44:45-56.
25. Zipeto D, Morris S, Hong C, et al. Human cytomegalovirus (CMV) DNA in plasma reflects quantity of CMV DNA present in leukocytes. J Clin Microbiol 1995;33:2607-2611.
26. Mendez J, Espy M, Smith TF, Wilson J, et al. Clinical significance of viral load in the diagnosis of Cytomegalovirus disease after liver transplantation. Transplant 1998;65:1477-1481.
27. Matchotka SV, Garrett CT, Schwartz AM, Callahan, R. Amplification of the proto-oncogene int-2, c-erb B2 and c-myc in human breast cancer. Clin Chim Acta 1898;184(3):207-217.
28. Ferreira-Gonzalez A, Fisher RA, Weymouth LA, et al. Clinical utility of a quantitative PCR for diagnosis of cytomegalovirus disease in solid organ trasnplant patients. Transplant, 1999;68:991-996.
29. nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1898.
30. Ferreira-Gonzalez A, Shiffman ML, Lofland DH, et al. Assessing clinical utility of hepatits C virus quantitative RT-PCR data: implications for identification of responders among α-interferon-treated patients. Mol Diagnosis 1996;1:109-120.
31. Imbert-Marcille BM, Cantarovich D, Ferre-Aubine V, et al. Usefulness of DNA viral load quantification for cytomegalovirus disease monitoring in renal and pancreas/renal transplant recipients. Transplant 1997;63:1476-1481.
32. Mutimer D, Matyi-Toth A, Shaw J, et al. Patterns of viremia in liver transplant recipients with symptomatic cytomegalovirus infection. Transplant 1997;63:68-73.
33. Hebart H, Muller C, Loffler J, et al. Monitoring of CMV infection: a comparison of PCR from whole blood, plasma-PCR, pp65-antigenimia and virus culture in patients after bone marrow transplantation. Bone Marrow Transplant 1996;17:861-868.
34. Boivin G, Handfiels J, Toma E, et al. Compartive evaluation of the cytomegalovirus DNA load in polymorphonuclear leukocytes and plasma of human immunodeficiency virus-infected subjects. J Infect Dis 1998;177:355-360.